Mark Sullivan, CLO of Definium Therapeutics DFTX, has filed 0 purchases and 14 sales on the open market. Over the past 12 months that comes to a net sale of $1.4M. The latest trade was on 09/25.

Mark Sullivan

Chief Legal Officer

Company

Definium Therapeutics DFTX

First filing

23/03/06

Trades

21 trades

Buys / sales

0 / 14

12-month net buying

−$1.4M

Last trade

09/25

FollowShare

Trading activity

6 months1 year2 years5 yearsAll

Transactions

Company	Trade type	Traded	Filed	Shares	Price	Value	Holding change
Definium TherapeuticsDFTX	Open-market sale10b5-1 plan	09/25	09/29	14,051 sh	$36.57	$513,845.07	−2.8%
Definium TherapeuticsDFTX	Open-market sale10b5-1 plan	06/25	06/26	13,008 sh	$45.03	$585,750.24	−3.9%
Definium TherapeuticsDFTX	Open-market sale10b5-1 plan	03/25	03/26	10,702 sh	$18.47	$197,665.94	−3.8%
Definium TherapeuticsDFTX	Open-market sale10b5-1 plan	25/12/26	25/12/29	11,276 sh	$13.15	$148,279.4	−3.8%
Definium TherapeuticsDFTX	Open-market sale10b5-1 plan	25/09/25	25/09/26	11,278 sh	$9.77	$110,186.06	−3.7%
Definium TherapeuticsDFTX	Open-market sale10b5-1 plan	25/06/25	25/06/26	11,491 sh	$6.80	$78,138.8	−3.6%
Definium TherapeuticsDFTX	Open-market sale10b5-1 plan	25/03/25	25/03/26	6,576 sh	$6.74	$44,322.24	−2.0%
Definium TherapeuticsDFTX	Open-market sale10b5-1 plan	24/12/26	24/12/27	4,519 sh	$7.43	$33,576.17	−2.5%
Definium TherapeuticsDFTX	Open-market sale10b5-1 plan	24/09/25	24/09/25	4,430 sh	$5.98	$26,491.4	−2.4%
Definium TherapeuticsDFTX	Open-market sale10b5-1 plan	24/06/25	24/06/25	17,854 sh	$7.22	$128,905.88	−8.9%
CT Carisma Therapeutics	Open-market sale	23/03/02	23/03/06	219,218 sh3 trades	$0.59avg.	$129,338.62	−36.7%
CT Carisma Therapeutics	Open-market sale	23/02/21	23/02/23	39,831 sh	$0.59	$23,500.29	−11.7%